Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,103 public trials 2,042 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

A Clinical Study of SHP674 (Pegaspargase) in Participants With Newly Diagnosed, Untreated Acute Lymphoblastic Leukemia

NCT04067518

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Kagoshima University Hospital Department of Pediatrics Kagoshima, Japan
  • Kobe Children's Hospital Department of Hematology/Oncology Kobe, Japan
  • Nagoya Medical Center Department of Pediatrics Nagoya, Japan
  • Niigata Cancer Center Hospital Niigata, Japan
View Trial Details
Completed

Phase III Study of SyB L-0501 in Combination With Rituximab to Treat Recurrent/Relapsed Diffuse Large B-Cell Lymphoma

NCT03372837

Conditions
Assess the Efficacy and Safety of SyB L-0501 in Combination With Rituximab in Patients With Recurrent or Relapsed DLBCL, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Research Site Nagoya, Aichi-ken, Japan
  • Research Site Toyoake, Aichi-ken, Japan
  • Research Site Matsuyama, Ehime, Japan
  • Research Site Maebashi, Gunma, Japan
View all 29 locations
View Trial Details

Related conditions